Showing results (1451-1460 of 1,655) with videos related to
Sort By:
Pageof 166
Journal of the American Heart Association|May 22, 2025
Association of Lipoprotein(a) With Major Adverse Limb Events and All-Cause Mortality Following Revascularization for Chronic Limb-Threatening Ischemia: A Substudy of the BEST-CLI TrialAlexander E Sullivan, Shi Huang, Suman Kundu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 2020
Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19Jeffrey S Berger, Dennis Kunichoff, Samrachana Adhikari, et al.Cancer Cell|September 13, 2011
Asymmetry-defective oligodendrocyte progenitors are glioma precursorsSista Sugiarto, Anders I Persson, Elena Gonzalez Munoz, et al.Melanoma Research|December 1, 2022
Talimogene laherparepvec monotherapy for head and neck melanoma patientsViola Franke, Emma H A Stahlie, Willem M C Klop, et al.Journal of Neurosurgery|August 7, 2023
Genomic alterations associated with postoperative nodular leptomeningeal disease after resection of brain metastasesRamin A Morshed, Daniel D Cummins, Minh P Nguyen, et al.Journal of the American Heart Association|May 31, 2021
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLIDMarc D Samsky, Anne Hellkamp, William R Hiatt, et al.Vascular Medicine (London, England)|June 4, 2021
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trialJudith Hsia, Sarah T Kavanagh, Charles W Hopley, et al.Cell Reports|August 22, 2019
Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma AggressivenessHanna Sabelström, Rebecca Petri, Ksenya Shchors, et al.The New England Journal of Medicine|May 2, 2020
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19Harmony R Reynolds, Samrachana Adhikari, Claudia Pulgarin, et al.Pageof 166